Intravitreal autologous bone-marrow stem cells in nonexudative macular degeneration (dry AMD) patients: results after 3 months follow-up (2015)
- Authors:
- USP affiliated authors: MESSIAS, ANDRÉ MÁRCIO VIEIRA - FMRP ; JORGE, RODRIGO - FMRP
- Unidade: FMRP
- Subjects: DEGENERAÇÃO MACULAR; OFTALMOPATIAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Abstracts
- Conference titles: Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
-
ABNT
COTRIM, Carina Costa et al. Intravitreal autologous bone-marrow stem cells in nonexudative macular degeneration (dry AMD) patients: results after 3 months follow-up. 2015, Anais.. Rockville: ARVO, 2015. Disponível em: http://iovs.arvojournals.org/article.aspx?articleid=2333675&resultClick=1. Acesso em: 04 mar. 2026. -
APA
Cotrim, C. C., Jorge, R., Messias, A. M. V., Sousa, M. V. de, Toscano, L., & Siqueira, R. C. (2015). Intravitreal autologous bone-marrow stem cells in nonexudative macular degeneration (dry AMD) patients: results after 3 months follow-up. In Abstracts. Rockville: ARVO. Recuperado de http://iovs.arvojournals.org/article.aspx?articleid=2333675&resultClick=1 -
NLM
Cotrim CC, Jorge R, Messias AMV, Sousa MV de, Toscano L, Siqueira RC. Intravitreal autologous bone-marrow stem cells in nonexudative macular degeneration (dry AMD) patients: results after 3 months follow-up [Internet]. Abstracts. 2015 ;[citado 2026 mar. 04 ] Available from: http://iovs.arvojournals.org/article.aspx?articleid=2333675&resultClick=1 -
Vancouver
Cotrim CC, Jorge R, Messias AMV, Sousa MV de, Toscano L, Siqueira RC. Intravitreal autologous bone-marrow stem cells in nonexudative macular degeneration (dry AMD) patients: results after 3 months follow-up [Internet]. Abstracts. 2015 ;[citado 2026 mar. 04 ] Available from: http://iovs.arvojournals.org/article.aspx?articleid=2333675&resultClick=1 - Intravitreal ranibizumab for persistent new vessels in diabetic retinopathy
- Retinal safety and efficacy of a dexamethasone biodegradable implant to treat macular edema associated to retinal vein occlusion: a phase I/II clinical trial
- Intravitreal use of bone marrow mononuclear fraction containing CD34+ stem cells in patients with atrophic age-related macular degeneration
- Intravitreal bevacizumab or triamcinolone combined with macular laser photocoagulation for diabetic macular edema: preliminary results
- Ranibizumabe intravítreo no pré-operatório de vitrectomia em pacientes diabéticos com descolamento de retina tracional
- Intravitreal autologous bone marrow derived stem cells in dry age-related macular degeneration
- Intravitreal autologous bone marrow derived stem cells in ischemic maculopathy
- Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study
- Foveal thickeness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema
- Intravitreal injection versus sub-tenon S infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
